Oral Abstract Session:
86. Clostridium difficile: Detection, Transmission, and Treatment
Friday, October 21, 2011: 2:15 PM-4:15 PM
Room: 151AB

Learning Objectives:

none

Target Audience: other, Academicians

Topical Category: N. Hospital-acquired and surgical infections, infection control, and health outcomes including general public health and health services research

Tracks: Pediatric ID, Adult ID

Moderators:  Kent A. Sepkowitz, MD, FIDSA, Memorial Sloan Kettering Cancer Center and Sapna A. Mehta, MD, New York University School of Medicine

Presentations:

2:15 PM
753
Comparison of C. difficile Testing Approaches at a Large Tertiary-Care Hospital
Jonathan Grein, MD ; Margaret Ochner, MD ; Angela Jin, MPH ; Ha Hoang, MPH ; Margie Morgan, PhD ; Rehka Murthy, MD

2:30 PM
754

2:45 PM
755
Characterisation of Clostridium difficileHospital Ward-Based Transmission Using Extensive Epidemiological Data and Molecular Typing
David Eyre ; A. Sarah Walker, PhD ; David Wyllie ; Kate Dingle ; Rosalind Harding ; Lily O'Connor ; David Griffiths ; Ali Vaughan ; John Finney ; Mark Wilcox ; Derrick Crook, MB BCh ; Tim Peto, MB BS, DPhil

3:00 PM
756

3:15 PM
757
Disordered Distal Gut Microbiota in Clostridium difficile Infection Revealed by High Density Deep Sequencing
Vijay Antharam, PhD ; Eric Li, MS ; Arif Ishmael, MD ; Anuj Sharma, MD ; Volker Mai, PhD ; Kenneth Rand, MD ; Gary Wang, MD, PhD

3:45 PM
759
Renal Impairment and Response to Fidaxomicin versus Vancomycin in Patients with Clostridium difficile Infection
Kathleen Mullane, DO, FIDSA ; Yoav Golan, MD MS ; Derrick Crook, MB BCh ; Oliver Cornely, MD, FIDSA ; Mark Miller, MD, MSc ; Thomas Louie, M D ; Sherwood Gorbach, MD, FIDSA

4:00 PM
760
Safety and Immunogenicity of a Novel Clostridium difficile Candidate Vaccine in Adults and the Elderly
Richard N Greenberg, MD ; Thomas Marbury, MD ; Ginamarie Foglia, DO, MPH

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

K. A. Sepkowitz, Department of Defense: Investigator, Research grant

S. A. Mehta, None

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.